These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12412826)

  • 21. Single-center, single-dose, open-label, randomized, two-period crossover study on the bioavailability of methotrexate administered using a novel prefilled, needle-free delivery system.
    Bienvenu B; Aouba A; Gottenberg JE; Verstuyft C
    Curr Med Res Opin; 2017 Apr; 33(4):605-611. PubMed ID: 27874307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intranasal delivery of recombinant human growth hormone (somatropin) in sheep using chitosan-based powder formulations.
    Cheng YH; Dyer AM; Jabbal-Gill I; Hinchcliffe M; Nankervis R; Smith A; Watts P
    Eur J Pharm Sci; 2005 Sep; 26(1):9-15. PubMed ID: 15970435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relative bioavailability and pharmacokinetics of a new sibutramine formulation in healthy male subjects: a randomized, open-label, two-period, comparative crossover study.
    Park JY; Kim KA; Park PW; Suh KH; Lee GS
    Clin Ther; 2004 Dec; 26(12):2092-101. PubMed ID: 15823773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioequivalence of canakinumab liquid pre-filled syringe and reconstituted lyophilized formulations following 150 mg subcutaneous administration: a randomized study in healthy subjects.
    Chioato A; Noseda E; Colin L; Matott R; Skerjanec A; Dietz AJ
    Clin Drug Investig; 2013 Nov; 33(11):801-8. PubMed ID: 24030571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a novel sustained release formulation of recombinant human growth hormone using sodium hyaluronate microparticles.
    Kim SJ; Hahn SK; Kim MJ; Kim DH; Lee YP
    J Control Release; 2005 May; 104(2):323-35. PubMed ID: 15907583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth hormone therapy with a new delivery system.
    Jørgensen JT; Susgaard S
    Indian J Pediatr; 1991; 58 Suppl 1():43-50. PubMed ID: 1824374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A single-dose, randomized, two-way crossover study comparing two olanzapine tablet products in healthy adult male volunteers under fasting conditions.
    Elshafeey AH; Elsherbiny MA; Fathallah MM
    Clin Ther; 2009 Mar; 31(3):600-8. PubMed ID: 19393850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and Pharmacodynamics of Follicle-Stimulating Hormone in Healthy Women Receiving Single and Multiple Doses of Highly Purified Human Menotrophin and Urofollitrophin.
    Di Stefano AF; Rusca A; Radicioni MM; Loprete L; Binelli D; Caccia G; Cometti B
    Clin Drug Investig; 2016 Dec; 36(12):1031-1044. PubMed ID: 27638053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic bridging approach for developing biologics-delivery devices: a case study with a golimumab autoinjector.
    Xu Z; Marciniak SJ; Frederick B; Kim L; Zhuang Y; Davis HM; Zhou H
    Clin Ther; 2015 Feb; 37(2):427-38. PubMed ID: 25438720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioavailability of recombinant human growth hormone in different concentrations and formulations.
    Vahl N; Jensen SB; Rasmussen MH; Susgaard S; Jørgensen JO; Christiansen JS; Rasmussen UF; Hilsted J
    Pharmacol Toxicol; 1996 Sep; 79(3):144-9. PubMed ID: 8884873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and bioequivalence study of three oral formulations of valsartan 160 mg: a single-dose, randomized, open-label, three-period crossover comparison in healthy Indian male volunteers.
    Iqbal M; Khuroo A; Batolar LS; Tandon M; Monif T; Sharma PL
    Clin Ther; 2010 Mar; 32(3):588-96. PubMed ID: 20399995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of concentration and injection volume on the bioavailability of subcutaneous growth hormone: comparison of administration by ordinary syringe and by injection pen.
    Blok GJ; van der Veen EA; Susgaard S; Larsen F
    Pharmacol Toxicol; 1991 May; 68(5):355-9. PubMed ID: 1946180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
    Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
    Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and pharmacodynamics of GH: dependence on route and dosage of administration.
    Keller A; Wu Z; Kratzsch J; Keller E; Blum WF; Kniess A; Preiss R; Teichert J; Strasburger CJ; Bidlingmaier M
    Eur J Endocrinol; 2007 Jun; 156(6):647-53. PubMed ID: 17535864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychological responses to the needle-free Medi-Jector or the multidose Disetronic injection pen in human growth hormone therapy.
    Verrips GH; Hirasing RA; Fekkes M; Vogels T; Verloove-Vanhorick SP; Delemarre-Van de Waal HA
    Acta Paediatr; 1998 Feb; 87(2):154-8. PubMed ID: 9512200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioavailability and bioequivalence of two oral formulations of alendronate sodium 70 mg: an open-label, randomized, two-period crossover comparison in healthy Korean adult male volunteers.
    Rhim SY; Park JH; Park YS; Lee MH; Kim DS; Shaw LM; Yang SC; Kang JS
    Clin Ther; 2009 May; 31(5):1037-45. PubMed ID: 19539104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pegvisomant bioavailability of single 30 mg/mL subcutaneous injection compared to two 15 mg/mL subcutaneous injections: a pharmacokinetic, safety and tolerability study.
    Jen J; LaBadie RR; Liang Y; Crownover PH; Gao X; Hey-Hadavi JH
    Growth Horm IGF Res; 2013 Aug; 23(4):114-9. PubMed ID: 23651793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
    Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioequivalence between novel ready-to-use liquid formulations of the recombinant human GH Omnitrope and the original lyophilized formulations for reconstitution of Omnitrope and Genotropin.
    Fuhr U; Tuculanu D; Berghout A; Balser S; Schwebig A; Saenger P
    Eur J Endocrinol; 2010 Jun; 162(6):1051-8. PubMed ID: 20332125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.